首页> 美国卫生研究院文献>Cell Death Disease >GRP75 modulates oncogenic Dbl-driven endocytosis derailed via the CHIP-mediated ubiquitin degradation pathway
【2h】

GRP75 modulates oncogenic Dbl-driven endocytosis derailed via the CHIP-mediated ubiquitin degradation pathway

机译:GRP75通过CHIP介导的泛素降解途径调节致癌的Dbl驱动的内吞作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chaperone-assisted proteasome degradation of oncogenic protein acts as an upstream signal controlling tumorigenesis and progression. The understanding of the co-regulation of chaperone and oncoprotein of endocytosis pathways is extremely limited. In this study, we showed for the first time that proto-Dbl (dbl proto-oncogene product) is co-enriched with mitochondrial chaperone GRP75 in endocytosis vesicles from ovarian cancer cells. onco-Dbl, produced by oncogenic mutation/degradation of proto-Dbl, markedly enhanced cellular macropinocytosis but suppressed clathrin-mediated endocytosis and clathrin-independent endocytosis pathways, presenting a derailed endocytosis phenotype. GRP75 was associated with proto-Dbl inside cells and modulated Dbl-driven endocytosis derailed by a co-regulatory mode. In spite of not being a component of the Hsc70/Hsp90/proto-Dbl complex, the degradation of proto-Dbl was promoted by GRP75 through the CHIP-mediated ubiquitin–proteasome pathway, of which GRP75 acts as a cooperator with CHIP but also acts as a competitor to Hsc70 and Hsp90 in the multiple chaperones-assisted pro-folding/pro-degradation machinery. Knockdown or inhibition of GRP75 attenuated proto-Dbl degradation and reduced the onco-Dbl level, which differentially impaired Rho GTPases activation and therefore shifted the endocytosis-derailed phenotype. Our data uncovered a novel GRP75-Dbl endocytosis regulatory axis and provided an alternative using chaperone inhibitor to shut down the oncoprotein-driven endocytosis derailment mechanism.
机译:伴侣蛋白辅助的致癌蛋白蛋白酶体降解充当控制肿瘤发生和发展的上游信号。对伴侣蛋白和内吞途径的癌蛋白的共调节的理解是非常有限的。在这项研究中,我们首次证明在卵巢癌细胞的内吞小泡中,proto-Dbl(dbl原癌基因产物)与线粒体伴侣GRP75共同富集。原癌基因Dbl的致癌突变/降解产生的癌基因-Dbl显着增强了细胞巨胞吞作用,但抑制了网格蛋白介导的内吞作用和网格蛋白非依赖性内吞作用通路,表现出脱轨的内吞作用表型。 GRP75与细胞内的原Dbl相关联,并通过共调控模式使经调制的Dbl驱动的胞吞作用脱轨。尽管不是Hsc70 / Hsp90 / proto-Dbl复合物的组成部分,但GRP75通过CHIP介导的泛素-蛋白酶体途径促进了Proto-Dbl的降解,其中GRP75与CHIP协同起作用在多种伴侣辅助的折叠/降解机器中作为Hsc70和Hsp90的竞争对手。击倒或抑制GRP75减弱了原Dbl的降解并降低了Onco-Dbl的水平,从而差异性地损害了Rho GTPases的活化,因此改变了内吞作用导致的表型。我们的数据揭示了一种新型的GRP75-Dbl内吞作用调控轴,并提供了一种使用伴侣抑制剂来关闭癌蛋白驱动的内吞作用脱轨机制的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号